1 of 1
Story summary
- Amazon Web Services launched Amazon Bio Discovery, an AI application designed to accelerate early-stage drug discovery.
- The platform lets scientists run complex workflows without coding and access specialized biological models to generate and evaluate drug molecules.
- Researchers can send candidates to lab partners for testing, streamlining the process.
- Rajiv Chopra of AWS says drug-discovery models bottleneck translating lab goals into pipelines, and AWS will introduce an AI platform to enhance trial-site selection.
